about
Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas.RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapyTargeting lactate transport suppresses in vivo breast tumour growthMonocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targetsIn Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas.The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER InhibitorsLactate Transporters and pH Regulation: Potential Therapeutic Targets in Glioblastomas.Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells.Differential sensitivities to lactate transport inhibitors of breast cancer cell lines.Tumor Growth Suppression Induced by Biomimetic Silk Fibroin Hydrogels.The monocarboxylate transporter inhibitor α-cyano-4-hydroxycinnamic acid disrupts rat lung branching.Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells.Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy.Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk.Angiogenic potential of gellan-gum-based hydrogels for application in nucleus pulposus regeneration: in vivo study.Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells.Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic TargetsCD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistanceThe metabolic landscape of urological cancers: New therapeutic perspectivesXIST-Promoter Demethylation as Tissue Biomarker for Testicular Germ Cell Tumors and Spermatogenesis QualityThe Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer RadioresistanceThe Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma
P50
Q34146377-D17BDAE1-939D-41B8-AE41-B4F06810A245Q34634649-617EB7E0-F28F-4A4D-93CC-034756009F12Q36326353-6047F321-E94D-4839-AE3B-9258E3A40CFBQ36544108-5635199B-EDCB-43B6-B7A0-375C88450062Q36723791-1F072977-D317-48CD-AAB9-7DAB2C8E9A84Q37068082-E313BFF2-FBE7-4321-A92C-22E4DDF52D6CQ37564738-B1470332-B95B-4CD4-86B6-9F14C9EC03DAQ37668572-92D4CB26-0EB1-4977-8A20-740ADDF9F0CCQ38676275-A365F1DC-A261-4139-8109-A91C679364ADQ38869917-9A099459-00E9-4222-915F-725D9EA9D407Q39068526-D8A645C9-0E9E-4691-8899-7D905301A5FDQ41869468-8D4D9488-A7D0-4A4B-B7AA-4D3B65A04D08Q46546362-97C52409-7404-4B45-BAAB-8974884BE5A2Q47114557-6D22A6ED-8675-4720-B95D-356F2E506C71Q47823735-9CCAFCEE-665B-42DD-8257-D3E135AC2C2FQ47859447-03A3A19C-67E1-478A-B385-B26FE25B09C3Q47992770-654E550A-A3E3-4844-A729-A0D62491C719Q55456779-C38CB4F3-5B89-462B-9ECB-F7A288635950Q57816641-DC1FCD31-AC0F-4DB2-B0DD-79CF0369A419Q58850422-08EB8C55-72B3-4DE8-8F83-7833BDE1FBA3Q90111482-C92D3D33-C727-4472-8FCE-A7D778A9B9C3Q90164325-8E64AFC6-BBE0-4742-B35D-3465FAECE8B9Q91325519-0DC4E059-7CB4-488B-A89C-3770EC03310DQ93102798-9594F2D4-8501-4375-A309-9F0C2B8B5F55
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Vera Miranda-Gonçalves
@ast
Vera Miranda-Gonçalves
@en
Vera Miranda-Gonçalves
@es
Vera Miranda-Gonçalves
@nl
type
label
Vera Miranda-Gonçalves
@ast
Vera Miranda-Gonçalves
@en
Vera Miranda-Gonçalves
@es
Vera Miranda-Gonçalves
@nl
prefLabel
Vera Miranda-Gonçalves
@ast
Vera Miranda-Gonçalves
@en
Vera Miranda-Gonçalves
@es
Vera Miranda-Gonçalves
@nl
P106
P1153
47361242700
P214
49150516774903442793
P31
P496
0000-0002-4231-5532